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Abstract
Objective: To evaluate the quality of reports of complementary and alternative medicine (CAM)
randomized controlled trials (RCTs) in the pediatric population. We also examined whether there
was a change in the quality of reporting over time.
Methods: We used a systematic sample of 251 reports of RCTs that used a CAM intervention.
The quality of each report was assessed using the number of CONSORT checklist items included,
the frequency of unclear allocation concealment, and a 5-point quality assessment instrument.
Results: Nearly half (40%) of the CONSORT checklist items were included in the reports, with
an increase in the number of items included. The majority (81.3%) of RCTs reported unclear
allocation concealment with no significant change over time. The quality of reports achieved
approximately 40% of their maximum possible total score as assessed with the Jadad scale with no
change over time. Information regarding adverse events was reported in less than one quarter of
the RCTs (22%) and information regarding costs was mentioned in only a minority of reports (4%).
Conclusions: RCTs are an important tool for evidence based health care decisions. If these
studies are to be relevant in the evaluation of CAM interventions it is important that they are
conducted and reported with the highest possible standards. There is a need to redouble efforts
to ensure that children and their families are participating in RCTs that are conducted and reported
with minimal bias. Such studies will increase their usefulness to a board spectrum of interested
stakeholders.
Introduction
The use of complementary and alternative medicine
(CAM) has become increasingly popular for both adult
and pediatric populations. For example, in 1992, 11% of
a Montreal-based pediatric sample used CAM [1]. By
1997, however, this figure had grown to 17% [2]. The
1994 National Population Health Survey suggested that
15% of Canadians (any age) had used CAM during the
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course of the preceding year [3]. By 1999, this figure had
grown to roughly 70% [4]. Similar data has been reported
for other jurisdictions [5,6].
What is less clear is the quality of evidence for the use of
these products and practices. Focusing our attention on
reports of randomized controlled trials (RCTs) allows us
to examine the gold standard for evaluating an interven-
tion's effectiveness. This enables readers to judge the ex-
tent to which the results are internally valid and free of
bias.
Within conventional medicine there is substantial evi-
dence about the quality of reports of RCTs and the conse-
quences of lower quality reporting. Schulz and colleagues
have documented that only about a third of reports of
RCTs adequately report allocation concealment [7]. Re-
ports of inadequate allocation concealment, compared to
those in which this information is adequately reported
(i.e., adequate allocation concealment), exaggerate the es-
timates of an intervention's effectiveness by about 30%,
on average [8–10]. These investigations and others have
typically focused on interventions such as pharmaceuti-
cals and adult populations.
We are unaware of any systematic effort to examine the ex-
tent of bias in reports of CAM RCTs specifically targeted at
pediatric populations. This is important because if CAM
studies are not subjected to rigorous evaluations they may
jeopardize the health of children and their families [11].
Our primary focus was to evaluate the quality of reports of
RCTs in the pediatric population (PedCAM). As a second-
ary question we also examined whether there was a
change in the quality of reporting over time.
Methods
We have previously described the assembly of a compre-
hensive database of PedCAM RCTs [12]. Briefly, after de-
fining CAM we searched 13 bibliographic databases using
one of three search strategies. We also identified RCTs
from cited references of 47 PedCAM systematic reviews
[13]. The search results were downloaded to a reference
database and screened. After identifying the PedCAM
RCTs, clusters of trials relating to specific disease condi-
tions and intervention types were identified. Three mem-
bers of the research team (DM, MS, LL) nominated
clusters for further consideration. Our goal was to identify
300 trials for closer examination, ensuring broad coverage
of diseases and interventions from the full set of identified
reports.
Once these reports were retrieved we extracted descriptive
information using a 17-item structured data collection
form. The questions pertained to the type of CAM used,
the condition under investigation (according to the Inter-
national Classification of Disease – ICD-9), the number
and gender of the included children, the number and type
of outcomes used, information about the reporting of ad-
verse events and whether the authors reported on any cost
information. The complete questionnaire can be obtained
from the authors.
We also completed a comprehensive quality assessment
of each report using three methods. First, the revised
CONSORT statement checklist [14] was modified so that
multiple items were listed separately, which resulted in 32
items. Each item was assigned a yes or no response de-
pending on whether or not the author had reported it.
Second, the reporting of allocation concealment was as-
sessed as adequate, inadequate, or unclear [8] Third, the
Jadad scale [15], which contains two questions each on
randomization and masking, and one question on report-
ing of dropouts and withdrawals, was used to assess qual-
ity. Each question contains a yes or no response option. In
total, five points can be awarded with higher points indi-
cating superior quality. Three reviewers (DM, LL and MS)
completed all of these evaluations.
We did not conduct any formal training prior to evaluat-
ing the RCTs using any of the three methods. We have ex-
tensive experience using these methods and have
previously conducted training with results indicating sub-
stantial agreement between raters [16]. Discrepancies
were resolved by consensus between the three raters.
We compared the number of checklist criteria included in
each report and the mean number of criteria included
within each subheading as specified in the CONSORT
checklist. We also assessed the percentage of studies that
reported unclear allocation concealment and the specific
item and overall quality score derived from the Jadad in-
strument. The number of CONSORT checklist items re-
ported was compared over time (1970s, 1980s, 1990s,
2000s) using an analysis of variance. A similar approach
was used to assess the individual components and overall
total score of the Jadad scale. The percentage of unclear al-
location concealment was evaluated using χ 2 tests.
Results
Database searching identified 3580 citations. Of these
2975 were screened from which 1468 PedCAM RCTs were
identified (Figure 1). We systematically sampled 301 of
these reports for further study. Twenty reports failed to
meet our eligibility criteria and a further 30 reports were
not evaluated (Figure 1) leaving 251 reports from which
descriptive information and quality assessment was com-
pleted (Table 1).
The reported objective of CAM intervention was to man-
age or minimize current symptoms in two thirds of the re-BMC Pediatrics 2002, 2 http://www.biomedcentral.com/1471-2431/2/2
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ports (66.7%) and more than a quarter of the RCTs were
undertaken to help prevent disease (32.5%). There were
157 reports involving fewer than 100 children (mean =
47.31; standard deviation = 24.14); 63 reports included
between 100 and 1000 children (mean = 298.38; standard
deviation = 232.51); and 9 reports included more than
1000 children (mean = 6766; standard deviation =
8402.72).
Forty percent (12.7 out of 32) of the CONSORT checklist
items were included in the reports of PedCAM RCTs (Ta-
ble 2). There was an increase over time (p < 0.001) in the
number of checklist items included in the reports (Table
2). Between the 1980s, when 10.8 checklist items were re-
ported, and the 1990s, when 13.4 checklist items were re-
ported, there was a 24% increase in the number of
checklist items reported (p = 0.001; mean difference = -
2.55 (95% confidence interval: -4.28, -0.81). There was a
minor decrease in the 2000s in the number of CONSORT
items reported.
The majority (83.1%) of RCTs reported unclear allocation
concealment (Table 3). We were unable to detect a change
over time (p = 0.496; Table 3). The quality of reports
achieved approximately 40% of their maximum possible
total score as assessed by using the Jadad scale (Table 3).
There was no improvement in the quality of reporting
over time (p = 0.174).
Information regarding adverse events was reported in less
than one quarter of the RCTs (22.4%). Similarly, informa-
tion regarding costs (e.g., cost effectiveness) was men-
tioned in only a minority of reports (4.5%).
Discussion
About one third of the CONSORT checklist items were in-
cluded in reports of PedCAM RCTs. Although there is still
considerable room for improvement in how these studies
are reported, there has been a notable increase in the qual-
ity of their reports since the 1980s. The 24% increase in
the number of reported CONSORT items is encouraging
and probably reflects important reductions in bias in the
results of RCTs. Similar results were observed when the as-
sessments focused on the adequacy of allocation conceal-
ment or the Jadad assessment. Unfortunately, these results
also suggest that the validity of some of the PedCAM RCT
results is probably questionable. This is particularly true if
our attention focuses on aspects of how randomization
was reported. Only about half of the reports documented
how the random numbers were generated and three quar-
ters of the reports had unclear allocation concealment.
Conducting a randomized trial is a complex series of tasks
and it may not always be possible to minimize some po-
tential biases. For example, double blinding (masking) is
questionable both ethically and scientifically when per-
forming surgical trials. However, in every single rand-
omized trial it is always possible to ensure that the
random numbers are appropriately generated (e.g., com-
puter generation) and concealed from all parties involved
in the trial until the child has been randomized (e.g., cen-
tralized randomization). High quality reports always in-
clude this information.
Our results indicate that the quality of reports of PedCAM
RCTs may be lower than that found for conventional
medicine. It is difficult to be more certain because the de-
gree of journal overlap between different studies is un-
known. In a recent report on the assessment of 77 RCTs
published in 1998, in three high impact factor journals,
the average number of CONSORT items included was
27.1 (out of 40) [16]. The average Jadad score was 62% of
the maximum possible score and 39% of the reports had
unclear allocation concealment. Linde and colleagues re-
cently reported on the quality of 207 trials in homeopa-
thy, herbs and acupuncture [17]. The average Jadad score
ranged from about 40% (acupuncture) to 60% (herbs) of
the maximum possible total score. The Jadad scores are
similar to those observed in this study. However, the
CONSORT results reported here are considerably lower
than observed elsewhere.
Figure 1
Flow of citations and articles through the phases of screening
and eligibility evaluation
2975 records screened
1507 Failed to meet inclusion criteria:
680 Not an RCT
134  Not pediatric
682 Not a CAM intervention
11  No clinical outcome
301 selected for further study 
1468 PedCAM RCTs identified
3580 records identified through database  searching 
1 additional trial identified through the reference 
lists of systematic reviews
606 duplicate records removed
20 Failed to meet inclusion criteria:
11 Not  RCTs
5 Double publication or abstract of a full 
report already included
  4 No clinical outcome
251 Quality & descriptive data reported
30 Not evaluated:
 22  Language of publication*
   8 Unable to obtain a copy of the report
*Due to the language in which the paper was written, we were not able to read these 
papers in enough detail to reliably extract information: German (2), Hungarian (1), French 
(1), Japanese (2), Chinese (16). Note that there were some German and some French 
papers that we were able to include.BMC Pediatrics 2002, 2 http://www.biomedcentral.com/1471-2431/2/2
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Table 1: Conditions and Interventions selected for further study
Condition Original N N after Exclusions
Asthma 34 31
Colic 19 16
Dermatological conditions (including scars) 36 30
Diarrhea 75* 49
Malaria 21 20
Migraine / headache 19 18
Interventions / Treatment modalities Biofeedback 27 22
Chinese Herbal Medicine 20% 6
Chiropractic 75
Homeopathy 96
Massage or holding 26 25
TENS 88
Zinc 45 39
* We examined only 49 of 75 diarrhea studies to avoid giving undue weight to this condition. %Many of these were excluded based on language 
Note: some trials involved both a condition and a treatment chosen (i.e., chiropractic for colic) and so numbers to not total to 251.
Table 2: CONSORT checklist criteria included in 251 reports of complementary and alternative medicine randomized controlled trials 
in children published over four decades
Total number of items Decade
1970s (n = 5) 1980s (n = 47) 1990s (n = 186) 2000s (n = 13) Total (n = 251)
Title = 1,n% 2 (40.0) 29 (61.7) 144 (77.4) 12 (92.3) 187 (74.5)
Introduction = 1, n % 5 (100.0) 42 (89.4) 170 (91.4) 11 (84.6) 228 (90.8)
Methods = 18, mean (sd) 5.0 (3.7) 5.8 (1.8) 7.1 (2.6) 6.5 (2.9) 6.8 (2.5)
Results = 9, mean (sd) 1.0 (1.0) 1.6 (0.9) 2.5 (1.8) 2.2 (1.9) 2.3 (1.7)
Discussion = 3, mean (sd) 1.2(1.3) 2.0 (1.1) 2.1 (1.0) 1.9 (1.1) 2.0 (1.0)
Total = 32, mean (sd) 8.6 (5.4) 10.8 (3.0) 13.4 (4.3) 12.3 (5.3) 12.7 (4.3)
Table 3: Quality of reports of 251 complementary and alternative medicine randomized controlled trials in children using the Jadad 
assessment scale and the adequacy of allocation concealment
Total number of items Decade
1970s (n = 5) 1980s (n = 47) 1990s (n = 186) 2000s (n = 13) Total (n = 251)
Randomization, mean (sd) 0.2 (0.8) 0.7 (0.7) 1.0 (0.6) 1.2 (0.6) 0.9 (0.6)
Double-blinding, mean (sd) 0.8 (1.1) 0.6 (0.9) 0.6 (0.9) 0.6 (0.9) 0.6 (0.9)
Withdrawals/dropouts, n (%) 2 (40.0) 12 (25.5) 89 (47.8) 2 (15.4) 105 (41.8)
Overall = 5, mean (sd) 1.4 (1.7) 1.6 (1.3) 2.0 (1.2) 2.0 (1.5) 1.9 (1.3)
Unclear allocation concealment, n (%) 4 (80.0) 41 (87.2) 150 (80.6) 9 (69.2) 204 (81.3)BMC Pediatrics 2002, 2 http://www.biomedcentral.com/1471-2431/2/2
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One way to improve the quality of reporting of PedCAM
RCTs is for more pediatric journals to endorse the CON-
SORT statement. There is evidence to suggest that journals
using the CONSORT statement, compared to those not
doing so, have higher quality reports of RCTs [15]. Of
course examining the quality of reporting is 'after the fact'
when the trial is already completed. CONSORT can also
be used by granting agencies [18]; (Allan Bernstein, Presi-
dent of the Canadian Institutes of Health Research, per-
sonal communication) to encourage prospective
investigators to improve the conduct of their RCTs.
It is not immediately clear why we observed lower quality
scores in these reports. It is possible that the PedCAM
community conducts fewer RCTs and is therefore less ex-
perienced. We have observed that prior to 1975 there were
very few published reports of PedCAM RCTs [12], al-
though there has been a sharp increase in the number of
reports during the 1990s. These results might also reflect
that the PedCAM community has been slower to train re-
searchers in the appropriate conduct of RCTs.
Beyond examining the quality of these reports we were
disappointed to find that so few reports mentioned any-
thing about adverse events. This result is similar to that re-
cently reported [19]. Although information on adverse
events is extremely important authors have typically de-
voted less space to this information than to their names
and affiliations [20]. Only about one in twenty reports
mentioned anything about costs, such as a cost benefit
analysis, in their reports. If clinicians and policy makers
are to make decisions about the utility of CAM interven-
tions for the pediatric population they will need more in-
formation than simply the efficacy of the intervention.
This study had a number of limitations. Our focus was on
the quality of reporting of PedCAM RCTs. It is possible
that the trials were appropriately conducted but had defi-
ciencies in their reporting. Despite the paucity of data ad-
dressing this important question, the evidence that is
available points in the direction of a reasonably good cor-
relation between how investigators conduct their trials
and how they are subsequently reported [21,22]. We did
not take a random sample of all 1468 trials identified. It
is possible that our sample does not reflect the total pop-
ulation and that these results cannot be generalized to all
PedCAM RCTs. We selected the reports to broadly reflect
the ICD categories and CAM interventions of the 1468 re-
ports. We believe that our sampling approach although
systematic is representative and enables us to generalize
the observed results. The 2000s results need to be inter-
preted with caution and are probably not representative of
the population, as there were only 13 reports. The small
number probably reflects the delay in indexing the studies
on electronic databases. We excluded 22 reports because
they were written in languages other than English. It is
possible that the quality of these reports differs in some
systematic way from English language reports. Previous
research suggests that the quality of RCTs reported in non-
English languages is similar to those reported in English
[23].
Randomized trials are an important tool for evidence
based health care decisions. If these studies are to be rele-
vant in the evaluation of CAM interventions it is impor-
tant that they are conducted and reported with the highest
possible standards. There is a need to redouble efforts to
ensure that children and their families are participating in
RCTs that are conducted and reported with minimal bias.
Such studies will increase their usefulness to a board spec-
trum of interested stakeholders.
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